Cyclin-dependent kinase inhibitor p57KIP2 in soft tissue sarcomas and Wilms' tumors

Cancer Research

Volumn 56, Issue 6, 1996, Pages 1219-1221

  Orlow, Irene ^a   Iavarone, Antonio ^b   Crider Miller, Shyra J ^c   Bonilla, Félix ^a   Latres, Esther ^a   Lee, Mong Hong ^b   Gerald, William L ^a   Massagué, Joan ^b   Weissman, Bernard E ^c   Cordón Cardó, Carlos ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE; ENZYME INHIBITOR;

ARTICLE; CANCER GENETICS; DNA SEQUENCE; GENE DELETION; HUMAN; MAJOR CLINICAL STUDY; NEPHROBLASTOMA; POINT MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SINGLE STRAND CONFORMATION POLYMORPHISM; SOFT TISSUE SARCOMA; TISSUE DISTRIBUTION;

ADULT; BASE SEQUENCE; CHILD; CHROMOSOMES, HUMAN, PAIR 11; CYCLIN-DEPENDENT KINASE INHIBITOR P57; GENE DELETION; GENES, TUMOR SUPPRESSOR; GENES, WILMS TUMOR; HUMANS; KIDNEY NEOPLASMS; MOLECULAR SEQUENCE DATA; NEOPLASM PROTEINS; NUCLEAR PROTEINS; POINT MUTATION; POLYMERASE CHAIN REACTION; SARCOMA; WILMS TUMOR;

EID: 0029878892     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Xiong, Y., Hannon, G. J., Zhang, H., Casso, D., Kobayashi, R., and Beach, D. p21 is a universal inhibitor of cyclin kinases. Nature (Lond.), 366: 701-704, 1993.
2. El-Deiry, W. S., Tokino, T , Velculescu, V. E , Levy, D. B., Parsons, R., Trent, J M., Lin, D , Mercer, W. E., Kinzler, K. W., and Vogelstein, B WAF1, a potential mediator of p53 tumor suppression Cell, 75: 817-825, 1993
3. Kip1 a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell. 78: 59-66, 1994.
4. 1 cyclin-cdk protein kinase activity, is related to p21 Cell, 78: 67-74, 1994.
5. KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution. Genes & Dev., 9. 639-649, 1995.
6. CIP1 Cdk inhibitory family, is a candidate tumor suppressor gene. Genes & Dev., 9: 650-662, 1995.
7. Waga, S , Hannon, G. J , Beach, D., and Stillman, B. The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA. Nature (Lond.), 369: 574-578, 1994
8. Michieli, P., Chedid, M., Lin, D., Pierce, J. H , Mercer, W. E , and Givol, D. Induction of WAF1/CIP1 by a p53-independent pathway. Cancer Res., 54: 3391-3395, 1994.
9. Kip1, a cyclin-cdk inhibitor, links transforming growth factor-β and contact inhibition to cell cycle arrest. Genes & Dev., 8: 9-22, 1994.
10. Scrable, H., Witte, D., Shimada, H., Seemayer, T., Wang-Wuu, S., Soukup, S., Koufus, A., Houghton, P., Lampkin, B., and Cavenee, W. Molecular differential pathology of rhabdomyosarcoma. Genes Chromosomes & Cancer. 1: 23-35, 1989.
11. Loh, W. E., Jr, Scrable, H. J , Livanos, E , Arboleda, M. J., Cavenee, W. K., Oshimura, M., and Weissman, B. E. Human chromosome 11 contains two different growth suppressor genes for embryonal rhabdomyosarcoma. Proc. Natl. Acad. Sci. USA, 89: 1755-1759, 1992
12. Koufos, A., Grundy, P , Morgan, K., Aleck, K. A., Hadro, T., Lampkin, B. C., Kalbakji, A., and Cavence, W. K. Familial Wiedemann-Beckwith syndrome and a second Wilms' tumor locus both map to 11p15 5. Am. J. Hum. Genet , 44: 711-719, 1989.
13. Montagna, M., Menin, C., Chieco-Bianchi, L., and D'Andrea, E Occasional loss of constitutive heterozygosity at 11p15.5 and imprinting relaxation of the IGFII maternal allele in hepatoblastoma. J. Cancer Res. Clin. Oncol., 120: 732-736, 1994.
14. KIP2 gene and its analysis in the G40I Wilms' tumor assay. Cancer Res , 56: 1214-1218, 1996.
15. Cooper, C. S., and Clark, J Molecular biological studies on soft tissue sarcomas. Cancer Treat Res., 67. 37-55, 1993
16. Orlow, I., Lianes, P., Lacombe, L., Dalbagni, G., Reuter, V. E , and Cordon-Cardo, C Chromosome 9 allelic losses and microsatellite alterations in human bladder tumors. Cancer Res., 54: 2848-2851, 1994.
17. Gonzalez-Zulueta, M , Shibata, A., Ohneseit, P. F., Spruck, C. H., III, Busch, C., Shamaa, M., Elbaz, M., Nichols, P. W., Gonzalgo, M. L., Malstrom, P-U., and Jones, P. A. High frequency of chromosome 9p allelic loss and CDKN2 tumor suppressor gene alterations in squamous cell carcinoma of the bladder. J. Natl. Cancer Inst., 87: 1383-1395, 1995.
18. Orita, M., Suzuki, Y , Sekiya, T., and Hayashi, K. Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics. 5: 874-879, 1989
19. Dowdy, S. F., Fasching, C. L., Araujo, D., Lai, K-M., Livanos, E., Weissman, B. E., and Stanbridge, E J Suppression of tumorigenicity in Wilms' tumor by the p15.5-p14 region of chromosome 11. Science (Washington DC), 254: 293-295, 1991.
20. Pal, N., Wadey, R B., Buckle, B., Yeimans, E., Pritchard, J , and Cowell, J. K. Preferential loss of maternal alleles in sporadic Wilms' tumors. Oncogene, 5: 1665-1668, 1990.
21. Scrable, H., Cavenee, W , Ghavimi, F., Lovell, M , Morgan, K , and Sapienza, C. A model for embryonal rhabdomyosarcoma tumongenesis that involves genome imprinting. Proc. Natl. Acad. Sci. USA, 86. 7480-7484, 1989.
22. Albrecht, S., von Schweinitz, D , Waha, A , Kraus, J A , von Deimling, A., and Pietsch, T. Loss of maternal alleles on chromosome arm 11p in hepatoblastoma. Cancer Res., 54: 5041-5044, 1994.
23. Rainier, S., Johnson, L. A , Dobry, C J , Ping, A. J , Grundy, P. E., and Feinberg, A. P Relaxation of imprinted genes in human cancer. Nature (Lond.), 362. 747-749, 1993.
24. KIP2, a cyclin-dependent kinase inhibitor, in mouse. Nat Genet., 11: 204-206, 1995.
25. KIP2: chromosomal mapping to 12p12-12p13.1 and absence of mutations in human tumors. Cancer Res., 55: 1211-1214, 1995.
26. Kip1 gene to 12p13 and its analysis in leukemias. Cancer Res., 55: 1206-1210, 1995
27. Kip1, to regions involved in human cancer. Cancer Res., 55. 1199-1205, 1995
28. Cordon-Cardo, C Mutations of cell cycle regulators Biological and clinical implications for human neoplasia. Am J. Pathol. 147: 545-559, 1995
29. MacLachlan, T. K , Sang, N., and Giordano, A. Cyclins, cyclin-dependent kinases and Cdk inhibitors. Implications in cell cycle control and cancer. Crit Rev. Eukaryotic Gene Expr , 5: 127-156, 1995.